ValenTx's Unattributed Round

ValenTx raised a round of funding on February 24, 2003.

ValenTx is developing a = new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The company's technology mimics the therapeutic m…

Articles about ValenTx's Unattributed Round: